scholarly article | Q13442814 |
P50 | author | Don J. Diamond | Q37374385 |
Simon F Lacey | Q56978267 | ||
P2093 | author name string | W Zhou | |
A Krishnan | |||
A P Limaye | |||
C La Rosa | |||
P2860 | cites work | Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10 | Q24540441 |
Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients | Q33260989 | ||
Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease | Q33270851 | ||
Dysregulated cytokine responses during cytomegalovirus infection in renal transplant recipients | Q33353651 | ||
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection | Q34570624 | ||
PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy | Q34592551 | ||
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities | Q35850673 | ||
Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells | Q36403419 | ||
IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection | Q36509838 | ||
Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients | Q36728782 | ||
IL-10, T cell exhaustion and viral persistence | Q36750429 | ||
IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection | Q37068471 | ||
Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis | Q45153747 | ||
Programmed death-1 expression in liver transplant recipients as a prognostic indicator of cytomegalovirus disease. | Q45979494 | ||
Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes. | Q47581560 | ||
Differences in CMV-Specific T-Cell Levels and Long-Term Susceptibility to CMV Infection after Kidney, Heart and Lung Transplantation | Q60615092 | ||
Immunologic predictors of late cytomegalovirus disease after solid organ transplantation--an elusive goal? | Q79687916 | ||
Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis | Q79775594 | ||
Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation | Q80061563 | ||
Inconsistent responses of cytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendritic cells in organ transplant recipients | Q80583323 | ||
P433 | issue | 4 | |
P921 | main subject | Cytomegalovirus | Q6946 |
interleukins | Q194908 | ||
P304 | page(s) | 363-370 | |
P577 | publication date | 2010-01-11 | |
P1433 | published in | Transplant Infectious Disease | Q15749562 |
P1476 | title | Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease | |
P478 | volume | 12 |
Q36037639 | CD28 family and chronic rejection: "to belatacept...And beyond!". |
Q26998832 | Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation |
Q37188559 | Combined Detection of Serum IL-10, IL-17, and CXCL10 Predicts Acute Rejection Following Adult Liver Transplantation |
Q37359332 | Cytomegalovirus infections in solid organ transplantation: a review |
Q34616701 | Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma. |
Q35134243 | Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation |
Q42645889 | Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients |
Q38011227 | Immune response to CMV in solid organ transplant recipients: current concepts and future directions |
Q44050947 | Immunological insights into the pathogenesis of active CMV infection in non-immunosuppressed critically ill patients |
Q47585004 | Impact of donor and recipient human cytomegalovirus status on kidney transplantation. |
Q42244580 | Increased levels of PD-1 expression on CD8 T cells in patients post-renal transplant irrespective of chronic high EBV viral load. |
Q36389162 | Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients |
Q33932079 | Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients |
Q34164098 | Programmed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury |
Q90615815 | Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax |
Q36476646 | Role of TLR2-dependent IL-10 production in the inhibition of the initial IFN-γ T cell response to Porphyromonas gingivalis. |
Q36517022 | The immune response to human CMV |
Q84028052 | [Immunological monitoring strategies for cytomegalovirus infection. Immune-based therapies] |
Search more.